ArticleThe Lancet. Oncology2019

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.

Nieves Martínez Chanzá et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.